Biotech

All Articles

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has opened up a $700 million R&ampD center in the Boston ma Seaport, increasing its own R...

Boundless Bio helps make 'reasonable' discharges five months after $100M IPO

.Simply five months after safeguarding a $100 thousand IPO, Vast Bio is already laying off some empl...

Halda's $126M will definitely progress 'secure as well as kill' tumor medicines

.The preliminary phases of oncology R&ampD aren't except intriguing brand new techniques, as well as...

Lykos 'disappointments' not revealing study infractions with publisher

.Psychopharmacology has drawn three articles regarding midstage medical test records evaluating Lyko...

Analysts explore Avidity's DMD win, showing nuances in data

.Avidity Biosciences impressed clients with phase 1/2 information in Duchenne muscular dystrophy (DM...

Actinogen's cortisol blocker falls short period 2 depression research study

.Actinogen Medical's cortisol blocker has actually missed out on the primary endpoint of a phase 2 r...

Bivictrix chooses going personal only way to take ADC right into clinic

.Antibody-drug conjugates (ADCs) have actually gone to the center of numerous a billion-dollar biobu...

TPG tops up funds to $580M for expenditures across life scientific researches

.Property manager TPG, which has actually sustained biotechs including Sionna Therapies and also San...

Merck stops period 3 TIGIT test in lung cancer for futility

.Merck &amp Co.'s TIGIT program has actually suffered an additional setback. Months after shuttering...

After a hard year, Exscientia folds into Recursion

.After a year specified through pipe hairstyles, the departure of its CEO and also layoffs, Exscient...